Topoisomerase II Immunostaining as a Prognostic Marker for Survival in Ovarian Cancer
Author:
Publisher
Elsevier BV
Subject
Obstetrics and Gynecology,Oncology
Reference40 articles.
1. Age as a prognostic factor in ovarian carcinoma;Thigpen;The Gynecologic Oncology Group experience. Cancer,1993
2. Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience;Omura;J Clin Oncol,1991
3. Oncogene expression: long-term compared with short-term survival in patients with advanced epithelial ovarian cancer;Goff;Obstet Gynecol,1998
4. Clinical tumour markers in ovarian cancer;Mazurek;Eur J Cancer Prev,1998
5. The clinical predictivity of biomarkers of stage III–IV epithelial ovarian cancer in a prospective randomized treatment protocol;Silvestrini;Cancer,1998
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Expression of topoisomerase II, BCL-2, and Ki-67 in ovarian cancer tissue and their effects on the development and prognosis of ovarian cancers;EUR J GYNAECOL ONCOL;2017
2. Electrochemical immunosensor for detection of topoisomerase based on graphene–gold nanocomposites;Talanta;2014-07
3. Tissue Biomarkers in Prognostication of Serous Ovarian Cancer following Neoadjuvant Chemotherapy;BioMed Research International;2014
4. Prognostic importance of survivin, Ki-67, and topoisomerase IIα in ovarian carcinoma;Archives of Gynecology and Obstetrics;2013-08-22
5. Prognostication of prostate cancer based on TOP2A protein and gene assessment: TOP2A in prostate cancer;Journal of Translational Medicine;2013-02-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3